Pentacyclic triterpenes: New tools to fight metabolic syndrome
ConclusionIn vitro and in vivo studies suggests that pentacyclic triterpenes effectively downregulate various factors related to metabolic syndrome. These phytochemicals may serve as promising candidates for clinical trials for the management of metabolic syndrome.Graphical abstract
Source: Phytomedicine - Category: Drugs & Pharmacology Source Type: research
More News: Cardiology | Cardiovascular | Clinical Trials | Databases & Libraries | Diabetes | Eating Disorders & Weight Management | Endocrinology | Heart | Heart Attack | Hypertension | Insulin | Metabolic Syndrome | Mitochondria | Obesity | Science | Study